News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
817,045 Results
Type
Article (78266)
Company Profile (699)
Press Release (738080)
Section
Business (229713)
Career Advice (3943)
Deals (39367)
Drug Delivery (122)
Drug Development (89557)
Employer Resources (194)
FDA (17812)
Job Trends (17130)
News (390819)
Policy (39072)
Tag
Academia (2974)
Alliances (56154)
Alzheimer's disease (1367)
Approvals (17743)
Artificial intelligence (173)
Bankruptcy (391)
Best Places to Work (12572)
Biotechnology (479)
Breast cancer (200)
Cancer (1472)
Cardiovascular disease (126)
Career advice (3365)
Cell therapy (322)
Clinical research (71134)
Collaboration (528)
Compensation (271)
COVID-19 (2814)
C-suite (121)
Data (1430)
Diabetes (193)
Diagnostics (6711)
Earnings (93509)
Employer resources (167)
Events (126735)
Executive appointments (415)
FDA (18534)
Funding (458)
Gene therapy (222)
GLP-1 (721)
Government (5035)
Healthcare (20740)
Infectious disease (2916)
Inflammatory bowel disease (126)
Interviews (773)
IPO (17594)
Job creations (5033)
Job search strategy (2739)
Layoffs (494)
Legal (9964)
Lung cancer (218)
Manufacturing (236)
Medical device (14449)
Medtech (14454)
Mergers & acquisitions (21914)
Metabolic disorders (534)
Neuroscience (1725)
NextGen Class of 2024 (7635)
Non-profit (5069)
Northern California (1742)
Obesity (302)
Opinion (249)
Patents (127)
People (63700)
Pharmaceutical (143)
Phase I (21942)
Phase II (30986)
Phase III (23370)
Pipeline (532)
Postmarket research (3345)
Preclinical (9770)
Radiopharmaceuticals (258)
Rare diseases (293)
Real estate (7220)
Regulatory (25680)
Research institute (2643)
Resumes & cover letters (626)
Southern California (1508)
Startups (4249)
United States (16354)
Vaccines (669)
Weight loss (239)
Date
Today (36)
Last 7 days (639)
Last 30 days (2464)
Last 365 days (37937)
2024 (37768)
2023 (42567)
2022 (53928)
2021 (58723)
2020 (57669)
2019 (51326)
2018 (39109)
2017 (37002)
2016 (38037)
2015 (44094)
2014 (38982)
2013 (35311)
2012 (37265)
2011 (37285)
2010 (37199)
Location
Africa (1222)
Arizona (216)
Asia (48481)
Australia (8369)
California (4038)
Canada (1474)
China (324)
Colorado (184)
Connecticut (200)
Europe (110344)
Florida (552)
Georgia (146)
Illinois (457)
Indiana (245)
Maryland (687)
Massachusetts (3233)
Michigan (195)
Minnesota (316)
New Jersey (1162)
New York (1129)
North Carolina (880)
Northern California (1742)
Ohio (156)
Pennsylvania (954)
South America (1604)
Southern California (1508)
Texas (590)
Utah (116)
Washington State (438)
817,045 Results for "biotronik se and co kg".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Bio NC
Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KGKARL STORZ to provide up to $20 million in bridge financing
Asensus Surgical, Inc. announced that it has entered into a non-binding letter of intent with KARL STORZ SE & Co. KG, an independent, family-owned global medical technology company to engage in diligence and negotiations regarding the terms of a potential transaction whereby KARL STORZ may acquire Asensus.
April 3, 2024
·
9 min read
Press Releases
BioNxt Signs Letter of Intent with Gen-Plus GmbH & Co KG for Potential Business Collaborations
August 15, 2024
·
3 min read
Press Releases
Evotec SE Reports 9M 2024 Results: Strategic Progress and Successful Expansion Amid Challenging Market Conditions
November 6, 2024
·
7 min read
Press Releases
Merck’s Investigational Zilovertamab Vedotin in Combination With R-CHP Demonstrates Complete Response Rate of 100% at 1.75 mg/kg Dose in Phase 2 Trial of Previously Untreated Patients With Diffuse Large B-Cell Lymphoma
December 9, 2024
·
9 min read
Press Releases
Evotec SE announces first projects for LAB eN(2) drug discovery accelerator with Novo Nordisk
December 11, 2024
·
7 min read
BIOTRONIK and IMDS Join Forces to Launch Innovative Micro Rx Catheter
BIOTRONIK is proud to introduce the Micro Rx™ catheter, a novel rapid exchange microcatheter developed to easily enhance guidewire support during percutaneous coronary interventions.
February 8, 2024
·
3 min read
Business
Secarna Pharmaceuticals and Orbit Discovery Enter Collaboration to Discover and Develop Peptide-conjugated Targeted Antisense Oligonucleotide Therapeutics
Secarna Pharmaceuticals GmbH & Co. KG and Orbit Discovery Ltd. today announced that they have entered into a collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide (ASO) therapeutics.
May 28, 2024
·
2 min read
Business
Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer
The Supervisory Board of Evotec SE has appointed Dr Christian Wojczewski as the Company’s new Chief Executive Officer, effective 01 July 2024.
April 23, 2024
·
6 min read
Press Releases
Evotec SE to Announce Results for the First Nine Months 2024 on 06 November 2024
October 30, 2024
·
3 min read
Business
Evotec SE to Announce Results for First Quarter 2024 on 22 May 2024
Evotec SE will announce its financial results for the first quarter of 2024 on Wednesday, 22 May 2024.
May 15, 2024
·
3 min read
1 of 81,705
Next
